HEADER ION TRANSPORT 29-JUL-99 1C8S TITLE BACTERIORHODOPSIN D96N LATE M STATE INTERMEDIATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BACTERIORHODOPSIN ("M" STATE INTERMEDIATE); COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES; COMPND 6 OTHER_DETAILS: SCHIFF BASE LINKAGE BETWEEN LYS 216 (NZ) AND RET 301 COMPND 7 (C15) DIETHER LIPID BILAYER SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HALOBACTERIUM SALINARUM; SOURCE 3 ORGANISM_TAXID: 2242; SOURCE 4 EXPRESSION_SYSTEM: HALOBACTERIUM SALINARUM; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 2242 KEYWDS ION PUMP, MEMBRANE PROTEIN, RETINAL PROTEIN, LIPIDS, PHOTORECEPTOR, KEYWDS 2 HALOARCHAEA, D96N M INTERMEDIATE, ION TRANSPORT, MEROHEDRAL TWINNING EXPDTA X-RAY DIFFRACTION AUTHOR H.LUECKE REVDAT 7 16-OCT-24 1C8S 1 REMARK REVDAT 6 09-AUG-23 1C8S 1 REMARK REVDAT 5 03-NOV-21 1C8S 1 REMARK SEQADV LINK REVDAT 4 13-JUL-11 1C8S 1 VERSN REVDAT 3 24-FEB-09 1C8S 1 VERSN REVDAT 2 01-APR-03 1C8S 1 JRNL REVDAT 1 20-OCT-99 1C8S 0 JRNL AUTH H.LUECKE,B.SCHOBERT,H.T.RICHTER,J.P.CARTAILLER,J.K.LANYI JRNL TITL STRUCTURAL CHANGES IN BACTERIORHODOPSIN DURING ION TRANSPORT JRNL TITL 2 AT 2 ANGSTROM RESOLUTION. JRNL REF SCIENCE V. 286 255 1999 JRNL REFN ISSN 0036-8075 JRNL PMID 10514362 JRNL DOI 10.1126/SCIENCE.286.5438.255 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.LUECKE,B.SCHOBERT,H.-T.RICHTER,J.-P.CARTAILLER,J.K.LANYI REMARK 1 TITL STRUCTURE OF BACTERIORHODOPSIN AT 1.55 ANGSTROM RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 291 899 1999 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.1999.3027 REMARK 1 REFERENCE 2 REMARK 1 AUTH H.LUECKE,H.-T.RICHTER,J.K.LANYI REMARK 1 TITL PROTON TRANSFER PATHWAYS IN BACTERIORHODOPSIN AT 2.3 REMARK 1 TITL 2 ANGSTROM RESOLUTION REMARK 1 REF SCIENCE V. 280 1934 1998 REMARK 1 REFN ISSN 0036-8075 REMARK 1 DOI 10.1126/SCIENCE.280.5371.1934 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 12.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : THIN RESOLUTION SHELLS REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.173 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.172 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 734 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 14622 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.208 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.206 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 615 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 11753 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1510 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 297 REMARK 3 SOLVENT ATOMS : 14 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 0 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 7288 REMARK 3 NUMBER OF RESTRAINTS : 7357 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 ANGLE DISTANCES (A) : 0.021 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.261 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.031 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.032 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.016 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: SHELXL-97 SWAT, BABINET'S PRINCIPLE REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : NULL REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: MEROHEDRAL TWINNING RATIO OF 53:47 REMARK 4 REMARK 4 1C8S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-AUG-99. REMARK 100 THE DEPOSITION ID IS D_1000009434. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL; NULL REMARK 200 TEMPERATURE (KELVIN) : 100; NULL REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : ALS; ESRF REMARK 200 BEAMLINE : 5.0.2; ID13 REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 1; 1 REMARK 200 MONOCHROMATOR : NULL; NULL REMARK 200 OPTICS : NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD REMARK 200 DETECTOR MANUFACTURER : ADSC; MAR CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14622 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 7.600 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.33000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: ISOMORPHOUS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1C3W REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MO:WATER:PHOSPHATE, PH 5.6, CUBIC REMARK 280 LIPID PHASE, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 54.07800 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 54.07800 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 54.07800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 26710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -233.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 30.31550 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 52.50799 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -30.31550 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 52.50799 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 219 CB - CG - CD1 ANGL. DEV. = 4.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 34 109.71 -56.81 REMARK 500 MET A 68 60.40 -115.61 REMARK 500 ASP A 102 80.73 35.67 REMARK 500 LEU A 152 46.22 -68.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 LI1 A 601 REMARK 610 LI1 A 602 REMARK 610 LI1 A 603 REMARK 610 LI1 A 605 REMARK 610 LI1 A 606 REMARK 610 LI1 A 607 REMARK 610 LI1 A 608 REMARK 610 LI1 A 609 REMARK 610 LI1 A 610 REMARK 610 LI1 A 612 REMARK 610 LI1 A 613 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 605 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 606 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 607 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 608 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 609 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 610 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 612 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI1 A 613 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SQU A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RET A 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1C3W RELATED DB: PDB REMARK 900 BACTERIORHODOPSIN WILD TYPE AT 1.55 A RESOLUTION DBREF 1C8S A 5 222 UNP P02945 BACR_HALN1 5 222 SEQADV 1C8S ASN A 96 UNP P02945 ASP 96 ENGINEERED MUTATION SEQRES 1 A 196 THR GLY ARG PRO GLU TRP ILE TRP LEU ALA LEU GLY THR SEQRES 2 A 196 ALA LEU MET GLY LEU GLY THR LEU TYR PHE LEU VAL LYS SEQRES 3 A 196 GLY MET GLY VAL SER ASP PRO ASP ALA LYS LYS PHE TYR SEQRES 4 A 196 ALA ILE THR THR LEU VAL PRO ALA ILE ALA PHE THR MET SEQRES 5 A 196 TYR LEU SER MET LEU LEU GLY TYR GLY LEU THR MET VAL SEQRES 6 A 196 PRO PHE GLY GLY GLU GLN ASN PRO ILE TYR TRP ALA ARG SEQRES 7 A 196 TYR ALA ASP TRP LEU PHE THR THR PRO LEU LEU LEU LEU SEQRES 8 A 196 ASN LEU ALA LEU LEU VAL ASP ALA ASP GLN GLY THR ILE SEQRES 9 A 196 LEU ALA LEU VAL GLY ALA ASP GLY ILE MET ILE GLY THR SEQRES 10 A 196 GLY LEU VAL GLY ALA LEU THR LYS VAL TYR SER TYR ARG SEQRES 11 A 196 PHE VAL TRP TRP ALA ILE SER THR ALA ALA MET LEU TYR SEQRES 12 A 196 ILE LEU TYR VAL LEU PHE ASN VAL THR VAL VAL LEU TRP SEQRES 13 A 196 SER ALA TYR PRO VAL VAL TRP LEU ILE GLY SER GLU GLY SEQRES 14 A 196 ALA GLY ILE VAL PRO LEU ASN ILE GLU THR LEU LEU PHE SEQRES 15 A 196 MET VAL LEU ASP VAL SER ALA LYS VAL GLY PHE GLY LEU SEQRES 16 A 196 ILE HET LI1 A 601 32 HET LI1 A 602 41 HET LI1 A 603 18 HET LI1 A 605 8 HET LI1 A 606 8 HET LI1 A 607 38 HET LI1 A 608 18 HET LI1 A 609 16 HET LI1 A 610 40 HET LI1 A 612 18 HET LI1 A 613 13 HET SQU A 701 27 HET RET A 301 20 HETNAM LI1 1-[2,6,10.14-TETRAMETHYL-HEXADECAN-16-YL]-2-[2,10,14- HETNAM 2 LI1 TRIMETHYLHEXADECAN-16-YL]GLYCEROL HETNAM SQU 2,10,23-TRIMETHYL-TETRACOSANE HETNAM RET RETINAL HETSYN LI1 LIPID FRAGMENT HETSYN SQU LIPID FRAGMENT FORMUL 2 LI1 11(C42 H86 O3) FORMUL 13 SQU C27 H56 FORMUL 14 RET C20 H28 O FORMUL 15 HOH *14(H2 O) HELIX 1 1 GLU A 9 MET A 32 1 24 HELIX 2 2 ASP A 36 LEU A 62 1 27 HELIX 3 3 TYR A 79 VAL A 101 1 23 HELIX 4 4 ASP A 104 THR A 128 1 25 HELIX 5 5 VAL A 130 LEU A 152 1 23 HELIX 6 6 ASN A 176 GLY A 192 1 17 HELIX 7 7 PRO A 200 VAL A 217 1 18 HELIX 8 8 VAL A 217 ILE A 222 1 6 SHEET 1 A 2 PRO A 70 PHE A 71 0 SHEET 2 A 2 GLU A 74 GLN A 75 -1 O GLU A 74 N PHE A 71 LINK NZ LYS A 216 C15 RET A 301 1555 1555 1.31 SITE 1 AC1 11 ILE A 11 PHE A 54 LEU A 58 LEU A 62 SITE 2 AC1 11 VAL A 136 ILE A 140 ALA A 143 LI1 A 606 SITE 3 AC1 11 LI1 A 608 LI1 A 612 SQU A 701 SITE 1 AC2 8 TRP A 12 TYR A 131 PHE A 135 TRP A 138 SITE 2 AC2 8 ALA A 139 ALA A 196 LI1 A 603 LI1 A 608 SITE 1 AC3 6 LEU A 190 ALA A 196 VAL A 199 PRO A 200 SITE 2 AC3 6 LI1 A 602 LI1 A 610 SITE 1 AC4 3 ALA A 18 LEU A 22 LI1 A 606 SITE 1 AC5 5 THR A 17 ALA A 18 LEU A 22 LI1 A 601 SITE 2 AC5 5 LI1 A 605 SITE 1 AC6 9 ILE A 52 MET A 56 TYR A 64 TRP A 80 SITE 2 AC6 9 LEU A 87 GLY A 116 ILE A 117 VAL A 124 SITE 3 AC6 9 LEU A 127 SITE 1 AC7 4 ILE A 222 LI1 A 601 LI1 A 602 SQU A 701 SITE 1 AC8 2 VAL A 177 LI1 A 610 SITE 1 AC9 8 ASN A 176 VAL A 179 VAL A 180 SER A 183 SITE 2 AC9 8 ALA A 184 VAL A 187 LI1 A 603 LI1 A 609 SITE 1 BC1 13 GLY A 21 THR A 24 LEU A 28 ALA A 44 SITE 2 BC1 13 THR A 47 LEU A 48 ALA A 51 PHE A 54 SITE 3 BC1 13 ALA A 110 ILE A 117 ALA A 144 TYR A 147 SITE 4 BC1 13 LI1 A 601 SITE 1 BC2 2 LEU A 87 LEU A 95 SITE 1 BC3 6 LEU A 25 TYR A 26 SER A 214 LEU A 221 SITE 2 BC3 6 LI1 A 601 LI1 A 608 SITE 1 BC4 11 TRP A 86 THR A 90 LEU A 93 GLY A 122 SITE 2 BC4 11 TRP A 138 SER A 141 TRP A 182 TYR A 185 SITE 3 BC4 11 ASP A 212 ALA A 215 LYS A 216 CRYST1 60.631 60.631 108.156 90.00 90.00 120.00 P 63 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016493 0.009522 0.000000 0.00000 SCALE2 0.000000 0.019045 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009246 0.00000